UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation

Quartagno, M; Walker, AS; Babiker, AG; Turner, RM; Parmar, MKB; Copas, A; White, IR; (2020) Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation. Trials , 21 , Article 145. 10.1186/s13063-020-4070-4. Green open access

[thumbnail of Babiker_s13063-020-4070-4.pdf]
Preview
Text
Babiker_s13063-020-4070-4.pdf - Published Version

Download (953kB) | Preview

Abstract

Background. Non-inferiority (NI) trials are increasingly used to evaluate new treatments expected to have secondary advantages over standard of care, but similar efficacy on the primary outcome. When designing a NI trial with a binary primary outcome, the choice of effect measure for the NI margin has an important effect on sample size calculations; furthermore, if the control event risk observed is markedly different from that assumed, the trial can quickly lose power or the results become difficult to interpret. Methods. We propose a new way of designing NI trials to overcome the issues raised by unexpected control event risks by specifying a NI frontier, i.e. a curve defining the most appropriate non-inferiority margin for each possible value of control event risk. We propose a fixed arcsine difference frontier, the power-stabilising transformation for binary outcomes. We propose and compare three ways of designing a trial using this frontier. Results. Testing and reporting on the arcsine scale leads to results which are challenging to interpret clinically. Working on the arcsine scale generally requires a larger sample size compared to the risk difference scale. Therefore, working on the risk difference scale, modifying the margin after observing the control event risk, might be preferable, as it requires a smaller sample size. However, this approach tends to slightly inflate type I error rate; a solution is to use a lower significance level for testing. When working on the risk ratio scale, the same approach leads to power levels above the nominal one, maintaining type I error under control. Conclusions. Our proposed methods of designing NI trials using power-stabilising frontiers make trial design more resilient to unexpected values of the control event risk, at the only cost of requiring larger sample sizes when the goal is to report results on the risk difference scale.

Type: Article
Title: Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation
Open access status: An open access version is available from UCL Discovery
DOI: 10.1186/s13063-020-4070-4
Publisher version: https://doi.org/10.1186/s13063-020-4070-4
Language: English
Additional information: Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > MRC Clinical Trials Unit at UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health > Infection and Population Health
URI: https://discovery.ucl.ac.uk/id/eprint/10089464
Downloads since deposit
53Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item